Welcome to our dedicated page for Baxter Intl news (Ticker: BAX), a resource for investors and traders seeking the latest updates and insights on Baxter Intl stock.
Baxter International Inc. (NYSE: BAX) is a global medtech company whose news flow reflects its focus on connected care technologies, medical devices and advanced injectable therapies. On this page, readers can follow company announcements that illustrate how Baxter’s products and partnerships intersect with hospital operations, nursing workflows and patient safety.
Recent Baxter news highlights the launch of the Dynamo Series smart stretcher, designed for emergency departments, perioperative environments and patient transport services. Baxter reports that the Dynamo Series is intended to reduce the need for patient transfers, support a range of procedures in-stretcher, and incorporate technologies such as SafeView+ visual cues, bed exit alarms and optional connectivity to EMRs and nurse call systems to help prevent patient falls and support care teams.
Other updates include a multi-year strategic partnership with MUSC Health focused on integrating connected care technologies at the bedside. Baxter and MUSC Health describe objectives such as standardizing and simplifying bedside technologies, reducing documentation time, streamlining communication, improving nurse satisfaction and retention, and using real-time insights and advanced monitoring to enhance quality and safety outcomes.
Baxter also issues news on its infusion therapy portfolio, such as real-world data presented with The University of Texas Medical Branch on the Spectrum IQ large volume infusion pumps. These analyses examine how smart pump integration with electronic medical records may affect patient safety alerts, infusion programming time and clinician workload.
In addition, investors can find announcements on capital allocation decisions, including tender offers for senior notes, new note issuances and dividend declarations, as well as philanthropic news from the Baxter Foundation, such as grants to support STEM education through the Baxter Center for Science Education. Bookmark this page to access Baxter’s latest product, partnership, financial and community impact news in one place.
Amerant Bancorp (NYSE: AMTB) has announced the appointment of two new board members: Patricia "Patty" Morrison and Jack Kopnisky. Morrison brings extensive technology leadership experience as former CIO of Cardinal Health and board expertise from various Fortune 500 companies. Kopnisky contributes over 40 years of financial services experience, most recently serving as Executive Chairman of Webster Financial Corporation.
These appointments follow the addition of Lisa Lutoff-Perlo and Odilon Almeida Júnior to the board in January 2025, demonstrating Amerant's commitment to strategic growth and board strengthening as it aims to become Florida's bank of choice.
Baxter International (NYSE:BAX) has released its 2024 Corporate Responsibility Report, highlighting progress toward its 2030 sustainability goals. The company achieved a 13.5% reduction in greenhouse gas emissions compared to 2023 and invested $12 million in energy conservation projects.
Key accomplishments include investing $31.5 million in underserved communities, implementing circular economy initiatives, and maintaining top quartile workplace safety performance. The company completed 175 energy projects, including solar installations and a biomass-fired steam generator. Baxter's charitable giving reached over 100 countries, with $4 million specifically supporting communities affected by Hurricane Helene.
The report includes a double materiality assessment following the sale of its Kidney Care business in January 2025, along with SASB and TCFD indices for transparent reporting.
Baxter International (NYSE:BAX), a global medtech leader, announced its participation in the Goldman Sachs 46th Annual Global Healthcare Conference 2025. The company's Chief Financial Officer, Joel Grade, will deliver a presentation on Tuesday, June 10, 2025, at 10:40 a.m. Eastern Time. Investors and interested parties can access the live webcast of the presentation through Baxter's website (www.baxter.com). The presentation replay will remain available until December 7, 2025.
Baxter International (NYSE: BAX) has announced a quarterly cash dividend of $0.17 per share of common stock. The dividend will be paid on July 1, 2025, to stockholders of record as of May 30, 2025. Based on this quarterly distribution, the indicated annual dividend rate for Baxter shareholders stands at $0.68 per share of common stock.
The company recently launched Voalte Linq device with voice-activation technology and introduced room-temperature storage Hemopatch Sealing Hemostat in Europe.
Baxter, a global medtech leader, has announced its participation in the upcoming Bank of America Securities 2025 Health Care Conference. The presentation is scheduled for Tuesday, May 13, 2025, at 8:40 a.m. Pacific Time.
Joel Grade, Baxter's chief financial officer, will be representing the company at the conference. Interested parties can access the live webcast through www.baxter.com. The presentation recording will remain available for replay until Sunday, November 9, 2025.
Baxter International (NYSE:BAX), a global medtech leader, has announced it will host a conference call to discuss its first-quarter 2025 financial results. The call is scheduled for Thursday, May 1, 2025, at 7:30 a.m. Central Time. Investors can pre-register for the call through a provided registration link. The conference call will also be accessible via webcast through Baxter's website.
Baxter International Inc. (NYSE:BAX) has announced the launch of an enhanced version of Hemopatch Sealing Hemostat that can now be stored at room temperature in Europe. This evolution eliminates the need for refrigeration, making the product more accessible in operating rooms for immediate use during critical situations.
Hemopatch Sealing Hemostat is a ready-to-use absorbable collagen pad designed for tissue sealing, dura sealing, and hemostasis in both open and minimally invasive surgeries. The product consists of a soft, flexible collagen pad derived from bovine dermis, coated with NHS-PEG, and features blue squares on the non-coated side for differentiation.
According to real-world data across Europe, the product has demonstrated effectiveness in achieving rapid and sustainable hemostasis across various surgical specialties. This product enhancement is a result of collaboration between surgeons and Baxter, addressing the critical need for immediate access during surgical procedures.
Baxter International (NYSE:BAX) has announced its 2025 Annual Meeting of Stockholders will be held virtually on Tuesday, May 6, 2025 at 9 a.m. Central Time. The virtual format aims to provide accessible, safe, and cost-effective participation for all stockholders.
Stockholders of record can attend by accessing virtualshareholdermeeting.com/BAX2025 with their 16-digit control number. Questions can be submitted either before the meeting (April 22-May 5) through proxyvote.com or live during the event. Voting options include pre-meeting methods outlined in proxy materials or electronic voting during the meeting.
The meeting will also be accessible to guests in listen-only mode, though they won't have voting or question-asking privileges. Online access opens at 8:45 a.m. Central Time, and stockholders holding shares in 'street name' should follow their broker's instructions for attendance.
Baxter International (NYSE:BAX) unveiled its first voice-activated technology, the Voalte Linq device powered by Scotty assistant, at HIMSS25. This lightweight, wearable badge integrates with Baxter's connected care portfolio, including Voalte Mobile and Voalte Nurse Call systems.
The technology aims to streamline hospital communication through voice commands activated by saying 'Hey Scotty.' Key benefits include:
- Enhanced communication efficiency between care teams
- Integration with existing Baxter solutions for automated workflows
- Support for patient and staff safety through rapid response capabilities
The device addresses communication challenges in healthcare settings, where over 60% of sentinel events are caused by communication failures according to the Joint Commission. Voalte Linq will be available in the U.S. in the second half of 2025, supporting both facility-wide and unit-specific communication in areas such as Operating Room, Emergency Department, and Labor and Delivery.